These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 10750167)

  • 1. Side effect profiles of atypical antipsychotics, typical antipsychotics, or no psychotropic medications in persons with mental retardation.
    Advokat CD; Mayville EA; Matson JL
    Res Dev Disabil; 2000; 21(1):75-84. PubMed ID: 10750167
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Atypical antipsychotics have very different adverse effect profiles and should not be lumped together.
    Friedman JH
    Arch Intern Med; 2006 Mar; 166(5):586; author reply 586-7. PubMed ID: 16534048
    [No Abstract]   [Full Text] [Related]  

  • 3. Effects of antipsychotic medication on psychiatric service utilization and cost.
    Rothbard A; Murrin MR; Jordan N; Kuno E; McFarland BH; Stroup TS; Morrissey JP; Stiles PG; Boothroyd RA; Merwin E; Shern DL
    J Ment Health Policy Econ; 2005 Jun; 8(2):83-93. PubMed ID: 15998980
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Akathisia in adults with severe and profound intellectual disability: a psychometric study of the MEDS and ARMS.
    Garcia MJ; Matson JL
    J Intellect Dev Disabil; 2008 Jun; 33(2):171-6. PubMed ID: 18569404
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tardive dyskinesia associated with metoclopramide in persons with developmental disabilities.
    Matson JL; Mayville EA; Bielecki J; Smalls Y; Eckholdt CS
    Res Dev Disabil; 2002; 23(3):224-33. PubMed ID: 12102590
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Managing antipsychotic-induced tardive dyskinesia.
    Gardos G
    Drug Saf; 1999 Feb; 20(2):187-93. PubMed ID: 10082074
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oral health impacts of medications used to treat mental illness.
    Cockburn N; Pradhan A; Taing MW; Kisely S; Ford PJ
    J Affect Disord; 2017 Dec; 223():184-193. PubMed ID: 28759866
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative efficacy of typical and atypical antipsychotics as add-on therapy to mood stabilizers in the treatment of acute mania.
    Miller DS; Yatham LN; Lam RW
    J Clin Psychiatry; 2001 Dec; 62(12):975-80. PubMed ID: 11780879
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Movement disorders associated with neuroleptic treatment.
    Wirshing WC
    J Clin Psychiatry; 2001; 62 Suppl 21():15-8. PubMed ID: 11584982
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of behavior disorders in mental retardation: report on transitioning to atypical antipsychotics, with an emphasis on risperidone.
    Aman MG; Gharabawi GM;
    J Clin Psychiatry; 2004 Sep; 65(9):1197-210. PubMed ID: 15367046
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Extrapyramidal syndromes caused by antipsychotics.
    Jesić MP; Jesić A; Filipović JB; Zivanović O
    Med Pregl; 2012; 65(11-12):521-6. PubMed ID: 23297621
    [TBL] [Abstract][Full Text] [Related]  

  • 12. On the relationship of atypical and low-dose conventional antipsychotics with akathisia in a clinical patient population.
    Markkula J; Helenius H; Lauerma H
    Nord J Psychiatry; 2007; 61(2):152-7. PubMed ID: 17454730
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Akathisia--diagnostic dilemma and behavioral treatment.
    Mattoo SK; Singh G; Vikas A
    Neurol India; 2003 Jun; 51(2):254-6. PubMed ID: 14571019
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Current status of the Matson Evaluation of Drug Side Effects (MEDS).
    Matson JL; Cervantes PE
    Res Dev Disabil; 2013 May; 34(5):1849-53. PubMed ID: 23528442
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Substituting traditional antipsychotics with risperidone for individuals with mental retardation.
    Simon EW; Blubaugh KM; Pippidis M
    Ment Retard; 1996 Dec; 34(6):359-66. PubMed ID: 8990820
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Akathisia: problem of history or concern of today.
    Iqbal N; Lambert T; Masand P
    CNS Spectr; 2007 Sep; 12(9 Suppl 14):1-13. PubMed ID: 17805218
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Typical and atypical antipsychotics--the misleading dichotomy. Results from the Working Group 'Drugs in Psychiatry' (AGATE).
    Fischer-Barnicol D; Lanquillon S; Haen E; Zofel P; Koch HJ; Dose M; Klein HE;
    Neuropsychobiology; 2008; 57(1-2):80-7. PubMed ID: 18515977
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The inter-relationships of tardive dyskinesia, parkinsonism, akathisia and tardive dystonia: the Curaçao Extrapyramidal Syndromes Study II.
    van Harten PN; Hoek HW; Matroos GE; Koeter M; Kahn RS
    Schizophr Res; 1997 Aug; 26(2-3):235-42. PubMed ID: 9323356
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clozapine induced akathisia: a case report and review of the evidence.
    Grover S; Sahoo S
    Indian J Pharmacol; 2015; 47(2):234-5. PubMed ID: 25878393
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk factors for tardive dyskinesia in adults with intellectual disability, comorbid psychopathology, and long-term psychotropic use.
    Matson JL; Fodstad JC; Neal D; Dempsey T; Rivet TT
    Res Dev Disabil; 2010; 31(1):108-16. PubMed ID: 19720497
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.